Skip to main content
OpenTrials
Completed

NCT Number: NCT01023100

A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product Testers

This study will test the palatability of several different CP-690,550 oral preparations in trained product tester healthy volunteers.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Pfizer Investigational Site

Woburn, Massachusetts, 01801, United States

About this study

To develop a palatable pediatric oral solution dosage form of CP-690,550.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Trained healthy non-pregnant product testers, age 18-75

Exclusion criteria

  • Severe acute or chronic medical conditions, including hepatitis or tuberculosis infections or clinically significant laboratory abnormalities.

Treatment and study plan

CP 690,550 oral solutions

Drug

flavored and unflavored prototype CP-690,550 formulations

Primary outcomes

  1. A complete description of the sensory attributes of products (eg, aroma, flavor, texture, and mouthfeel).

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Pfizer

Industry

Registry information

Official study title

A Study In Trained Taste Panel Healthy Adult Volunteers To Investigate The Palatability Of Select Formulations Of CP-690,550 Oral Solution

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Dec 2, 2009
Registry last updated
Jun 16, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.